neonat
calf
diarrhea
ncd
common
gastroenter
infect
worldwid
threaten
cattl
product
caus
substanti
econom
loss
group
bovin
rotaviru
brv
caus
agent
ncd
rotaviru
belong
famili
reovirida
nonenvelop
viru
genom
enclos
three
concentr
layer
compos
segment
doublestrand
rna
encod
six
structur
protein
five
nonstructur
protein
accord
antigen
genet
variat
region
rotaviru
divid
seven
group
design
group
brv
major
viral
pathogen
ncd
differenti
g
glycoprotein
p
proteas
sensit
protein
type
base
antigen
respect
sporad
outbreak
brv
china
report
recent
although
clinic
cours
follow
rotaviru
infect
typic
short
viru
detect
faec
week
postinfect
diagnost
procedur
viral
cultur
rtpcr
serolog
prove
use
detect
pathogen
nevertheless
world
health
organ
recommend
use
enzym
immunoassay
diagnosi
rotaviru
infect
phage
random
peptid
librari
compos
pool
billion
heterolog
peptid
express
n
terminu
capsid
protein
filament
bacteriophag
phage
random
peptid
librari
base
phage
display
welldevelop
technolog
identifi
specif
ligand
target
protein
biopan
process
technolog
appli
mani
field
antibodi
engin
drug
discoveri
manufactur
pathogen
diagnosi
immunogen
develop
current
studi
initi
identifi
potenti
ligand
brv
use
phage
display
technolog
util
phage
bear
ligand
establish
phagebas
elisa
specif
feasibl
suitabl
novel
approach
compar
commonli
use
quantit
realtim
pcr
qpcr
context
differenti
brv
pathogen
monkey
kidney
epitheli
cell
grown
dulbecco
mem
fetal
bovin
serum
brv
strain
propag
cell
presenc
trypsin
final
concentr
purifi
differenti
centrifug
convent
protein
concentr
dilut
pb
measur
thermo
scientif
nanodrop
spectrophotomet
nanodrop
technolog
thermo
fisher
scientif
wilmington
de
calcul
absorb
ratio
accord
manufactur
instruct
phage
display
perform
base
instruct
reagent
kit
manufactur
new
england
biolab
minor
modif
first
round
pan
plate
coat
brv
concentr
ph
buffer
overnight
plate
block
h
skim
milk
dilut
volvol
tween
phosphatebuff
salin
pbst
follow
six
wash
tbst
mm
trishcl
ph
mm
nacl
volvol
tween
virus
incub
phage
librari
final
concentr
room
temperatur
min
gentl
rock
unbound
phage
remov
time
wash
tbst
bound
phage
elut
ad
elut
buffer
glycinehcl
ph
room
temperatur
min
eluat
neutral
trishcl
ph
harvest
follow
amplif
titrat
escherichia
coli
second
third
round
pan
done
similar
pan
process
except
gradual
increas
concentr
tween
volvol
tbst
fourth
round
pan
coat
virus
replac
supernat
cultur
phage
incub
supernat
room
temperatur
min
prior
fifth
round
pan
titer
phage
input
elut
buffer
output
amplif
ecoli
analyz
accord
manufactur
instruct
posit
phage
clone
identifi
indirect
elisa
briefli
elisa
plate
coat
brv
dilut
concentr
overnight
plate
block
bovin
serum
albumin
bsa
tb
buffer
tbsb
room
temperatur
h
follow
six
time
wash
tbst
individu
phage
last
round
biopan
concentr
ph
incub
coat
virus
h
polyclon
antibodi
dilut
tbsb
abcam
ad
well
h
six
wash
tbst
subsequ
horseradish
peroxidas
hrp
conjug
antirabbit
igg
antibodi
dilut
tbsb
sigma
ad
color
develop
done
use
ophenylenediamin
opd
substrat
valu
read
use
elisa
plate
reader
experi
perform
triplic
twelv
posit
phage
clone
select
amplifi
ecoli
follow
precipit
polyethylen
glycolnacl
genom
dna
phage
extract
purifi
use
plasmid
extract
kit
qiagen
germani
gene
encod
exogen
peptid
amplifi
pcr
use
purifi
dna
templat
sens
primer
antisens
primer
pcr
paramet
compos
min
cycl
togeth
final
extens
min
encod
amino
acid
sequenc
deduc
postsequenc
select
phage
use
diagnost
reagent
detect
panel
virus
compos
bovin
rotaviru
brv
bovin
herpesviru
type
bovin
viral
diarrhea
viru
bvdv
bovin
coronaviru
bcv
porcin
rotaviru
prv
porcin
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhea
viru
pedv
porcin
reproduct
respiratori
syndrom
viru
prrsv
virus
dilut
final
concentr
coat
onto
elisa
plate
overnight
follow
elisa
valu
determin
least
three
independ
experi
repeat
statist
signific
evalu
use
ttest
p
consid
statist
highli
signific
negativeposit
cutoff
valu
set
averag
od
ratio
field
neg
sampl
posit
sampl
phagebas
elisa
negativeposit
threshold
assay
determin
use
microsoft
excel
spreadsheet
gener
twenti
neg
sampl
twenti
posit
sampl
includ
repeat
analysi
intraassay
withinpl
repeat
three
replic
sampl
perform
plate
interassay
betweenrun
repeat
three
replic
sampl
run
differ
plate
differ
occas
mean
od
ratio
standard
deviat
sd
coeffici
variat
cv
three
replic
test
analyz
sensit
elisa
compar
qpcr
determin
minimum
quantiti
viru
detect
briefli
brv
concentr
mgml
serial
dilut
dmem
one
aliquot
dilut
use
phagebas
elisa
assay
anoth
aliquot
use
qpcr
phagebas
elisa
brv
coat
elisa
plate
overnight
well
block
skim
milk
h
room
temperatur
thereaft
select
phage
phage
complex
phage
display
librari
control
phage
dilut
pb
final
concentr
use
primari
antibodi
ad
onto
well
tripl
wash
tbst
well
sequenti
incub
antibodi
dilut
pb
h
hrpconjug
goat
antirabbit
antibodi
dilut
pb
h
valu
detect
phage
well
judg
posit
result
genom
equival
ge
brv
determin
qpcr
assay
use
sens
primer
gatggagcgactacatggtattttaat
antisens
primer
tggctgtgcatttggaaataat
design
amplifi
gene
bp
length
brv
sens
primer
gtatcctgactctcaagtaccccatt
antisens
primer
atggccggaacgttgaag
use
amplifi
housekeep
gene
betaactin
bp
length
use
intern
refer
volum
sampl
total
rna
rna
extract
commerci
avail
kit
haigen
china
accord
manufactur
instruct
revers
transcript
rna
primer
pmol
buffer
takara
china
mmulu
takara
rnase
inhibitor
dntp
mmeach
steril
water
gentli
mix
incub
min
h
min
cool
storag
subsequ
realtim
pcr
perform
use
abi
prism
realtim
pcr
machin
appli
biosystem
usa
realtim
pcr
mixtur
includ
cdna
templat
sybr
green
pcr
mix
sybr
taq
polymeras
rox
refer
dye
sens
primer
antisens
primer
steril
water
pcr
paramet
compos
min
cycl
express
level
brv
normal
betaactin
accord
compar
cycl
threshold
ct
method
use
quantif
recommend
manufactur
protocol
delta
ct
determin
sampl
analyz
duplic
qpcr
ge
determin
use
standard
curv
mean
standard
deviat
calcul
detect
limit
calcul
cdna
copi
per
reaction
receiv
oper
characterist
roc
analysi
spearman
test
run
use
spss
analyz
correl
ge
qpcr
correspond
od
valu
phagebas
elisa
past
immunoglobulin
use
treat
rotaviru
diarrhea
nevertheless
applic
immunoglobulin
rel
expens
sideeffect
uncertain
also
report
compound
isol
root
g
uralensi
may
potent
antirotaviru
agent
vivo
howev
antivir
effect
evalu
clinic
vaccin
although
progress
made
develop
live
attenu
oral
vaccin
improv
vaccin
still
need
particularli
develop
countri
due
unsatisfactori
effect
vaccin
present
effect
diagnost
test
screen
virus
import
prevent
brv
phage
display
technolog
good
approach
ligand
identif
target
phagedisplay
peptid
combinatori
librari
interact
hepat
b
viru
adenoviru
type
and
viru
sin
nombr
viru
hantaan
viru
avian
viru
coronaviru
select
studi
use
brv
immobil
target
follow
biopan
process
use
phage
display
peptid
librari
select
ligand
viru
virus
harvest
cell
perform
subtract
pan
decreas
potenti
reaction
background
addit
gradual
increas
concentr
tween
improv
specif
biopan
result
show
titer
elut
phage
increas
gradual
data
shown
last
pan
twelv
phage
clone
abl
bind
brv
identifi
elisa
contrast
control
phage
neglig
bind
abil
viru
figur
amplif
select
phage
genom
extract
gene
encod
peptid
express
surfac
recombin
phage
amplifi
pcr
three
deduc
peptid
sequenc
amino
acid
length
select
phage
identifi
tabl
phage
bear
peptid
hvhpplrphsdk
ypthhahttpvr
hatnhlptphnr
name
phage
hv
yp
ha
respect
sequenc
data
deposit
genbank
access
number
provid
avail
knowledg
first
report
regard
peptid
sequenc
bind
brv
experi
focus
analyz
role
peptidesmotif
infect
mechan
brv
use
phage
bear
specif
affin
peptid
brv
develop
phagemedi
diagnost
assay
brv
clearli
import
distinguish
brv
virus
might
caus
multipl
infect
therefor
select
phage
analyz
specif
recogn
brv
panel
select
virus
shown
figur
three
identifi
phage
capabl
recogn
brv
specif
rather
control
virus
p
contrast
control
phage
complex
phage
librari
neglig
reaction
virus
use
studi
amplif
phage
rel
cheap
specif
phage
identifi
studi
may
specif
inexpens
assay
reagent
detect
brv
test
need
analyz
util
phagemedi
elisa
detect
brv
clinic
sampl
cutoff
point
assay
determin
dsn
dsp
maxim
sum
fals
neg
fals
posit
result
minim
od
nm
neg
sampl
yp
hv
ha
rang
averag
yp
hv
ha
od
neg
sampl
elisa
yield
suitabl
cutoff
od
valu
indic
neg
sampl
yp
hv
ha
od
valu
posit
threshold
set
posit
sampl
yp
hv
ha
od
valu
repeat
test
done
compar
od
ratio
triplic
result
field
stool
sampl
test
plate
intraassay
repeat
differ
plate
differ
time
interassay
repeat
intraassay
cv
yp
hv
ha
posit
sampl
rang
median
valu
neg
sampl
rang
median
valu
interassay
cv
yp
hv
ha
posit
sampl
median
valu
wherea
cv
neg
sampl
median
valu
data
show
newli
develop
phagebas
elisa
repeat
rel
low
variat
evalu
diagnost
accuraci
phagemedi
elisa
qpcr
analysi
brv
detect
set
refer
comparison
elisa
result
figur
furthermor
correl
elisa
qpcr
evalu
determin
area
roccurv
auc
shown
figur
rocanalysi
high
compar
aucvalu
exceed
use
either
result
yp
hv
ha
one
matrix
roccurv
yp
hv
ha
respect
high
valu
close
roccurv
repres
highli
accur
test
phagemedi
elisa
rather
sensit
diagnost
approach
brv
depend
ge
qpcr
od
extinct
valu
establish
elisa
analyz
use
spearman
rank
test
spearman
test
spearman
rho
yp
hv
ha
respect
p
result
indic
stronger
correl
ge
qpcr
od
elisa
conclus
studi
first
time
identifi
potenti
ligand
brv
phage
bear
peptid
brv
potenti
good
diagnost
reagent
develop
novel
sensit
phagemedi
elisa
detect
brv
